Why is Sanofi India falling/rising?

As of 01-Aug, Sanofi India Ltd's stock price is currently at Rs 5,551.70, reflecting a decline of Rs 290.3, or 4.97%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 5.88%. It has also underperformed its sector by 1.81% today. The stock's performance over the past week shows a decrease of 4.94%, and over the past month, it has declined by 10.51%. Additionally, it is trading below all key moving averages, indicating a bearish trend. Despite these challenges, the company boasts a high management efficiency with a return on equity of 35.83% and a low debt-to-equity ratio, which are positive factors that may support its valuation in the long term.
In the broader market context, Sanofi India's recent performance contrasts sharply with the Sensex, which has only fallen by 1.06% over the past week. The pharmaceuticals and drugs sector has also seen a decline of 3.27%, indicating a challenging environment for the industry. Furthermore, the stock's liquidity is adequate, but there has been a notable decrease in investor participation, with delivery volume dropping by 31.58% compared to the five-day average. This lack of interest could be contributing to the stock's downward pressure, despite the company's strong fundamentals and institutional backing, which may not be enough to offset the current negative sentiment in the market.